Products | September 21, 2009

Aposense [18F]–ML-10

Aposense [18F]–ML-10

Related Content

News | Prostate Cancer
High-Speed Whole-Body SPECT Tracks Tumor Evolution, Helps Optimize Prostate Cancer Treatment Options

Sept. 26, 2025 — A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently ...

Time October 03, 2025
arrow
New PET Tracer Enables Same-Day Imaging of Triple-Negative Breast, Urothelial Cancers
News | Radiopharmaceuticals and Tracers
New PET Tracer Enables Same-Day Imaging of Triple-Negative Breast, Urothelial Cancers

Sept. 20, 2025 — A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative ...

Time September 18, 2025
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Prostate Cancer
Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis
News | SPECT-CT
Novel Radiotracer Produces High Quality Images of “Alzheimer’s Disease of the Heart”

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
An overview of the capabilities enabled by the slide-level foundation model (PRISM)
News | Artificial Intelligence
Paige Delivers the Power of Foundation Model Technology to Revolutionize Pharmaceutical and Life Science AI Development

May 30, 2024 — Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) ...

Time May 30, 2024
arrow
Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion
News | Radiation Oncology
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
Extending beyond brain tumors, empowering patients with treatment options in prostate cancer and other malignancies
News | Prostate Cancer
GT Medical Technologies, Inc and Theragenics Corporation Forge Distribution Partnership for Cesium-131

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
The study, led by principal investigator Nitin Ohri, M.D., a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center, aims to demonstrate the feasibility of PGHD collection during proton beam radiotherapy for lung cancer
News | Proton Therapy
Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Ga-68 has a very short half-life, which presents logistical challenges in distribution
News | Radiopharmaceuticals and Tracers
RLS Radiopharmacies Partners with Eckert and Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its strategic partnership with Icon Group, a worldwide leader in comprehensive cancer care.
News | Quality Assurance (QA)
IBA Acquires Radcal Corporation to Expand Medical Imaging Quality Assurance Offering and Strengthen US Presence

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now